Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q3 2024 Earnings Call Transcript

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q3 2024 Earnings Call Transcript November 8, 2024

Xeris Biopharma Holdings, Inc. beats earnings expectations. Reported EPS is $-0.06, expectations were $-0.09.

Operator: Hello and welcome to the Xeris Biopharma Third Quarter 2024 Financial Results Conference Call. My name is Harry and I’ll be your operator today. All lines are currently in listen-only mode and there’ll be an opportunity for Q&A after management’s prepared remarks. [Operator...